Lista de obras -

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial

artículo científico publicado en 2016

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers

artículo científico publicado en 2016

Apatinib for the treatment of gastric cancer

artículo científico publicado en 2016

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

artículo científico publicado en 2017

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

artículo científico

CDK4/6 inhibitors in HER2-positive breast cancer

artículo científico publicado en 2017

Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study

scientific article published on 29 December 2020

Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study

scientific article published on 11 July 2019

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

artículo científico publicado en 2018

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

artículo científico publicado en 2017

Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.

artículo científico publicado en 2014

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

artículo científico publicado en 2020

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

scientific article published on 27 November 2018

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response

artículo científico publicado en 2015

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma

artículo científico publicado en 2017

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer

artículo científico publicado en 2017

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

artículo científico

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials

artículo científico publicado en 2016

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

artículo científico publicado en 2015

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer

artículo científico publicado en 2016

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

artículo científico publicado en 2015

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

artículo científico publicado en 2016

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

artículo científico publicado en 2016

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.

artículo científico publicado en 2018

RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy

artículo científico publicado en 2015

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

artículo científico publicado en 2016

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

artículo científico publicado en 2016

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

scientific article published on 19 December 2018

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

artículo científico publicado en 2017

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

artículo científico publicado en 2015

Lista de obras de

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers

Apatinib for the treatment of gastric cancer

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

CDK4/6 inhibitors in HER2-positive breast cancer

Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study

Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.

RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?